Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

142.45USD
2 Jul 2015
Change (% chg)

$-1.15 (-0.80%)
Prev Close
$143.60
Open
$144.14
Day's High
$144.34
Day's Low
$141.12
Volume
176,804
Avg. Vol
244,707
52-wk High
$150.27
52-wk Low
$84.28

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation is focused on technologies that treat structural heart disease and critically ill patients. The Company is engaged in the development and commercialization of heart valve therapies. It is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or... (more)

Overall

Beta: 0.74
Market Cap(Mil.): $15,445.29
Shares Outstanding(Mil.): 107.56
Dividend: --
Yield (%): --

Financials

Search Stocks

Edwards gets U.S. approval for third generation heart valve

- The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

18 Jun 2015

UPDATE 1-Edwards gets U.S. approval for 3rd generation heart valve

June 17 - The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

18 Jun 2015

Edwards gets U.S. approval for 3rd generation heart valve

June 17 - The U.S. Food and Drug Administration on Wednesday said it approved Edwards Lifesciences Corp's Sapien 3 heart valve, the third-generation version of the company's system for replacing diseased aortic valves.

18 Jun 2015

Edwards stops small mitral heart valve study

- Edwards Lifesciences Corp on Tuesday said it stopped enrolling patients in a small study of its less-invasive mitral heart valve device due to the formation of blood clots associated with the procedure.

19 May 2015

Edwards Lifesciences 1st-qtr net profit doubles, sales rise 13 pct

April 23 - Medical device maker Edwards Lifesciences Corp said on Thursday quarterly net earnings doubled due to strong heart valve sales and a positive impact from foreign exchange.

24 Apr 2015

Low mortality, stroke seen with newest Edwards TAVR system: study

- Researchers on Sunday presented trial data showing very low mortality and stroke rates using the third generation version of Edwards Lifesciences Corp's non-invasive heart valve replacement system that could help support its U.S. approval.

15 Mar 2015

Low mortality, stroke seen with newest Edwards TAVR system -study

March 15 - Researchers on Sunday presented trial data showing very low mortality and stroke rates using the third generation version of Edwards Lifesciences Corp's non-invasive heart valve replacement system that could help support its U.S. approval.

15 Mar 2015

UPDATE 1-Edwards raises 2015 earnings forecast; sees bigger forex hit

Feb 3 - Edwards Lifesciences Corp on Tuesday raised its 2015 earnings forecast to reflect strong demand for its non-invasive heart valve replacement system, but revised its overall sales forecast to account for a larger negative impact of foreign exchange due to the strong dollar .

04 Feb 2015

Edwards raises 2015 earnings forecast; sees bigger forex hit

Feb 3 - Edwards Lifesciences Corp on Tuesday raised its 2015 earnings forecast to reflect strong demand for its non-invasive heart valve replacement system, but revised its overall sales forecast to account for a larger negative impact of foreign exchange due to the strong dollar .

04 Feb 2015

Competitors

Earnings vs. Estimates

Search Stocks